Premium
TWO CASES OF LYMPHOMA OF THE PAROTID GLAND FOLLOWING ABLATIVE RADIOIODINE THERAPY FOR THYROID CARCINOMA
Author(s) -
WISEMAN J. C.,
HALES I. B.,
JOASOO A.
Publication year - 1982
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1982.tb02637.x
Subject(s) - medicine , lymphoma , ablative case , thyroid , salivary gland , radiation therapy , parotid gland , radioiodine therapy , thyroid carcinoma , carcinoma , pathology , endocrinology , oncology
SUMMARY Two adult patients are described in whom 131 I therapy for thyroid carcinoma was followed by the development of non‐Hodgkin's lymphoma in salivary glands. Histologically one was lymphocytic and the other histiocytic. The total doses of 131 I given were 27 GBq (675 mCi) and 14 GBq (350 mCi), lymphoma presenting 10 and 3 years respectively after the initial therapeutic dose of 131 I. We suggest that the relationship is a causal one, because of the rarity of salivary gland lymphoma and the high dose of radiation to the salivary glands with this mode of therapy.